U.S., Feb. 19 -- ClinicalTrials.gov registry received information related to the study (NCT06833450) titled 'Reliability of IUS in Crohn's Disease' on Feb. 13.
Brief Summary: Transabdominal intestinal ultrasound (IUS) is gaining acceptance as a point-of-care test to objectively assess disease activity in Crohn's disease (CD).
In order to incorporate individual parameters in a future definition of transmural healing, and for the consistent application of IUS as a modality to assess treatment outcomes and establish therapeutic targets to ensure comparability between future studies, the inter-observer agreement should be determined for all relevant parameters.
Study Start Date: Jan. 19, 2022
Study Type: INTERVENTIONAL
Condition:
Crohn Di...